2020 KSM指南:绝经期激素治疗

2020-08-26 0 J Menopausal Med . 2020 Aug;26(2):69-98.

2020年8月,韩国更年期学会(KSM)发布了绝经期激素治疗指南。本文的主要目的是基于最新研究发现提供最新的关于绝经期激素治疗指导。内容涉及激素治疗前检查,绝经过渡期女性激素治疗,血管症状和生活质量,

中文标题:

2020 KSM指南:绝经期激素治疗

英文标题:

The 2020 Menopausal Hormone Therapy Guidelines

发布机构:

0

发布日期:

2020-08-26

简要介绍:

2020年8月,韩国更年期学会(KSM)发布了绝经期激素治疗指南。本文的主要目的是基于最新研究发现提供最新的关于绝经期激素治疗指导。内容涉及激素治疗前检查,绝经过渡期女性激素治疗,血管症状和生活质量,泌尿生殖萎缩和性功能障碍,冠状动脉疾病,脑卒中,静脉血栓栓塞,乳腺癌和其他癌症,认知障碍和阿尔茨海默氏症,抑郁,骨质疏松,少肌症,胆囊疾病和偏头痛,替勃龙治疗,雌激素复合物治疗等。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 KSM指南:绝经期激素治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=66ac21c0019e3645, title=2020 KSM指南:绝经期激素治疗 , enTitle=The 2020 Menopausal Hormone Therapy Guidelines, guiderFrom=J Menopausal Med . 2020 Aug;26(2):69-98., authorId=0, author=, summary=2020年8月,韩国更年期学会(KSM)发布了绝经期激素治疗指南。本文的主要目的是基于最新研究发现提供最新的关于绝经期激素治疗指导。内容涉及激素治疗前检查,绝经过渡期女性激素治疗,血管症状和生活质量,, cover=https://img.medsci.cn/2020920/1600615142983_2020535.jpg, journalId=0, articlesId=null, associationId=null, associationName=0, associationIntro=, copyright=0, guiderPublishedTime=Wed Aug 26 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月,韩国更年期学会(KSM)发布了绝经期激素治疗指南。本文的主要目的是基于最新研究发现提供最新的关于绝经期激素治疗指导。内容涉及激素治疗前检查,绝经过渡期女性激素治疗,血管症状和生活质量,泌尿生殖萎缩和性功能障碍,冠状动脉疾病,脑卒中,静脉血栓栓塞,乳腺癌和其他癌症,认知障碍和阿尔茨海默氏症,抑郁,骨质疏松,少肌症,胆囊疾病和偏头痛,替勃龙治疗,雌激素复合物治疗等。</p> </div> </div> </div>, tagList=[TagDto(tagId=8523, tagName=绝经期)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8523, guiderKeyword=绝经期, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6108, appHits=390, showAppHits=0, pcHits=843, showPcHits=5700, likes=4, shares=30, comments=15, approvalStatus=1, publishedTime=Sun Sep 20 23:45:29 CST 2020, publishedTimeString=2020-08-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Sep 20 23:19:07 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 18:02:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 KSM指南:绝经期激素治疗.pdf)])
2020 KSM指南:绝经期激素治疗.pdf
下载请点击:
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1201497, encodeId=ef1b120149e52, content=谢谢分享,拿走了~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/779634fdc8944a13a6da20900ae58236/e941130f9cc742b19b7379e5a172b9c0.jpg, createdBy=97c65381808, createdName=Ms🧐🧐🧐🧐🧐🧐, createdTime=Thu Mar 10 19:37:02 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014394, encodeId=ab4410143942a, content=学习了 不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/512da905d2d443f7a834bf7f1f65d2d1/ce6b4c4e8e77442fa8a22d303220db5a.jpg, createdBy=f1b85503152, createdName=ms6000000014307403, createdTime=Fri Sep 03 21:53:34 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008239, encodeId=5aa110082394a, content=希望学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f7f1464166, createdName=liangnao2000, createdTime=Mon Aug 16 08:43:09 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006634, encodeId=6d6d100663485, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43805569089, createdName=ms1000001788353300, createdTime=Tue Aug 10 14:02:53 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975242, encodeId=3de29e524239, content=希望不错吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66115194976, createdName=1472541dm06暂无昵称, createdTime=Sun Jun 20 21:58:00 CST 2021, time=2021-06-20, status=1, ipAttribution=)]
    2022-03-10 Ms🧐🧐🧐🧐🧐🧐

    谢谢分享,拿走了~

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1201497, encodeId=ef1b120149e52, content=谢谢分享,拿走了~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/779634fdc8944a13a6da20900ae58236/e941130f9cc742b19b7379e5a172b9c0.jpg, createdBy=97c65381808, createdName=Ms🧐🧐🧐🧐🧐🧐, createdTime=Thu Mar 10 19:37:02 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014394, encodeId=ab4410143942a, content=学习了 不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/512da905d2d443f7a834bf7f1f65d2d1/ce6b4c4e8e77442fa8a22d303220db5a.jpg, createdBy=f1b85503152, createdName=ms6000000014307403, createdTime=Fri Sep 03 21:53:34 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008239, encodeId=5aa110082394a, content=希望学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f7f1464166, createdName=liangnao2000, createdTime=Mon Aug 16 08:43:09 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006634, encodeId=6d6d100663485, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43805569089, createdName=ms1000001788353300, createdTime=Tue Aug 10 14:02:53 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975242, encodeId=3de29e524239, content=希望不错吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66115194976, createdName=1472541dm06暂无昵称, createdTime=Sun Jun 20 21:58:00 CST 2021, time=2021-06-20, status=1, ipAttribution=)]
    2021-09-03 ms6000000014307403

    学习了 不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1201497, encodeId=ef1b120149e52, content=谢谢分享,拿走了~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/779634fdc8944a13a6da20900ae58236/e941130f9cc742b19b7379e5a172b9c0.jpg, createdBy=97c65381808, createdName=Ms🧐🧐🧐🧐🧐🧐, createdTime=Thu Mar 10 19:37:02 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014394, encodeId=ab4410143942a, content=学习了 不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/512da905d2d443f7a834bf7f1f65d2d1/ce6b4c4e8e77442fa8a22d303220db5a.jpg, createdBy=f1b85503152, createdName=ms6000000014307403, createdTime=Fri Sep 03 21:53:34 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008239, encodeId=5aa110082394a, content=希望学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f7f1464166, createdName=liangnao2000, createdTime=Mon Aug 16 08:43:09 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006634, encodeId=6d6d100663485, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43805569089, createdName=ms1000001788353300, createdTime=Tue Aug 10 14:02:53 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975242, encodeId=3de29e524239, content=希望不错吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66115194976, createdName=1472541dm06暂无昵称, createdTime=Sun Jun 20 21:58:00 CST 2021, time=2021-06-20, status=1, ipAttribution=)]
    2021-08-16 liangnao2000

    希望学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1201497, encodeId=ef1b120149e52, content=谢谢分享,拿走了~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/779634fdc8944a13a6da20900ae58236/e941130f9cc742b19b7379e5a172b9c0.jpg, createdBy=97c65381808, createdName=Ms🧐🧐🧐🧐🧐🧐, createdTime=Thu Mar 10 19:37:02 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014394, encodeId=ab4410143942a, content=学习了 不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/512da905d2d443f7a834bf7f1f65d2d1/ce6b4c4e8e77442fa8a22d303220db5a.jpg, createdBy=f1b85503152, createdName=ms6000000014307403, createdTime=Fri Sep 03 21:53:34 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008239, encodeId=5aa110082394a, content=希望学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f7f1464166, createdName=liangnao2000, createdTime=Mon Aug 16 08:43:09 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006634, encodeId=6d6d100663485, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43805569089, createdName=ms1000001788353300, createdTime=Tue Aug 10 14:02:53 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975242, encodeId=3de29e524239, content=希望不错吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66115194976, createdName=1472541dm06暂无昵称, createdTime=Sun Jun 20 21:58:00 CST 2021, time=2021-06-20, status=1, ipAttribution=)]
    2021-08-10 ms1000001788353300

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1201497, encodeId=ef1b120149e52, content=谢谢分享,拿走了~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/779634fdc8944a13a6da20900ae58236/e941130f9cc742b19b7379e5a172b9c0.jpg, createdBy=97c65381808, createdName=Ms🧐🧐🧐🧐🧐🧐, createdTime=Thu Mar 10 19:37:02 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014394, encodeId=ab4410143942a, content=学习了 不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/512da905d2d443f7a834bf7f1f65d2d1/ce6b4c4e8e77442fa8a22d303220db5a.jpg, createdBy=f1b85503152, createdName=ms6000000014307403, createdTime=Fri Sep 03 21:53:34 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008239, encodeId=5aa110082394a, content=希望学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f7f1464166, createdName=liangnao2000, createdTime=Mon Aug 16 08:43:09 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006634, encodeId=6d6d100663485, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43805569089, createdName=ms1000001788353300, createdTime=Tue Aug 10 14:02:53 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975242, encodeId=3de29e524239, content=希望不错吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66115194976, createdName=1472541dm06暂无昵称, createdTime=Sun Jun 20 21:58:00 CST 2021, time=2021-06-20, status=1, ipAttribution=)]
    2021-06-20 1472541dm06暂无昵称

    希望不错吧

    0